Carson Wealth (CWM LLC)
XLRN

Carson Wealth (CWM LLC)’s Acceleron Pharma XLRN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3K Hold
21
– – ﹤0.01% 2600
2021
Q1 		$3K Hold
21
– – ﹤0.01% 2598
2020
Q4 		$3K Hold
21
– – ﹤0.01% 2597
2020
Q3 		$3K Hold
21
– – ﹤0.01% 2596
2020
Q2 		$3K Hold
21
– – ﹤0.01% 2594
2020
Q1 		$3K Hold
21
– – ﹤0.01% 2592
2019
Q4 		$3K Hold
21
– – ﹤0.01% 2591
2019
Q3 		$3K Hold
21
– – ﹤0.01% 2591
2019
Q2 		$3K Hold
21
– – ﹤0.01% 2591
2019
Q1 		$3K Buy
+21
New +$922 ﹤0.01% 2590

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Carson Wealth (CWM LLC)'s XLRN Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Acceleron Pharma (XLRN) position steady in Q2 2021 at 21 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

Carson Wealth (CWM LLC) first reported a position in XLRN in Q1 2019 and has held it in 10 quarters since. 271 funds tracked by Wall St. Rank hold XLRN as of Q2 2021.

  • Carson Wealth (CWM LLC) held 21 shares of Acceleron Pharma worth $3K as of Q2 2021.
  • Carson Wealth (CWM LLC) left its Acceleron Pharma share count unchanged in Q2 2021.
  • Acceleron Pharma made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #2600 holding.
  • Carson Wealth (CWM LLC) first reported a position in Acceleron Pharma in Q1 2019 and has held it in 10 quarters since.
  • 271 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.